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1,25-Dihydroxyvitamin D3 (vitamin D) and transform-
ing growth factor-b (TGF-b) regulate diverse biological
processes including cell proliferation and differentia-
tion through modulation of the expression of target
genes. Members of the Smad family of proteins function
as effectors of TGF-b signaling pathways whereas the
vitamin D receptor (VDR) confers vitamin D signaling.
We investigated the molecular mechanisms by which
TGF-b and vitamin D signaling pathways interact in the
regulation of the human osteocalcin promoter. Syner-
gistic activation of the osteocalcin gene promoter by
TGF-b and vitamin D was observed in transient trans-
fection experiments. However, in contrast to a previous
report by Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Su-
zawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T.,
Kawabata, M., Miyazono, K., and Kato, S. (1999) Science,
283, 1317–1321, synergistic activation was not detectable
when the osteocalcin vitamin D response element
(VDRE) alone was linked to a heterologous promoter.
Inclusion of the Smad binding elements (SBEs) with the
VDRE in the heterologous promoter restored synergis-
tic activation. Furthermore, this synergy was dependent
on the spacing between VDRE and SBEs. The Smad3-
Smad4 heterodimer was found to bind in gel shift assay
to two distinct DNA segments of the osteocalcin pro-
moter: 21030 to 2989 (SBE3) and 2418 to 2349 (SBE1).
Deletion of SBE1, which is proximal to the VDRE, but
not the distal SBE3 in this promoter reporter abolished
TGF-b responsiveness and eliminated synergistic
co-activation with vitamin D. Thus the molecular mech-
anism, whereby Smad3 and VDR mediate cross-talk be-
tween the TGF-b and vitamin D signaling pathways,
requires both a VDRE and a SBE located in close prox-
imity to the target promoter.
The biological actions of 1,25-dihydroxyvitamin D3 (vitamin
D)1 are mediated through the vitamin D receptor (VDR), a
member of the nuclear receptor superfamily (1). Although VDR
homodimers may play some role, most VDR actions are thought
to be mediated via VDR heterodimerization with the retinoid X
receptor (RXR) (2). The VDR/RXR heterodimers bind to vita-
min D response elements (VDREs) in the promoters of vitamin
D target genes (3, 4). VDREs typically consist of at least two
copies of the consensus motif, PuG(G/T)TCA, arranged as di-
rect repeats with a three-nucleotide spacing (DR3) (5). In ad-
dition to spacing, small differences in the half-site sequence,
and the sequence of the flanking extension of the response
elements also appear to be important in determining receptor
binding efficiency (Ref. 6 and references therein). Upon
binding, these receptors can either stimulate or repress tran-
scription of target genes (7), assisted by direct and indirect
interaction with other transcriptional regulatory proteins.
Such additional factors may be recruited by other regulatory
signals, such as TGF-b, which has been shown to act in synergy
with vitamin D (8, 9).
Transforming growth factor-b (TGF-b), like activin and bone
morphogenetic protein (BMP), signals through the Smad fam-
ily of intracellular transducing proteins (10). Among the
Smads, Smad2 and Smad3 are known to permit signaling by
TGF-b and activin ligands (11). Once phosphorylated, these
Smad proteins heterodimerize with Smad4, the common medi-
ator of TGF-b pathways. These complexes translocate to the
nucleus where they regulate target genes either by interacting
with DNA or with other transcription factors (11, 12). Though
a palindromic Smad binding element (SBE), GTCTAGAC, was
shown to interact with the Smad3 and Smad4 complex, the
smaller 4-bp half-site of this SBE DNA sequence, GTCT or
AGAC, has been shown to be sufficient to bind these proteins
(12, 13).
Although Smads can bind to DNA, Smad-DNA binding alone
is not always sufficient for gene activation. There are now a
growing number of examples in which Smads cooperate with
DNA-binding partners to regulate transcription (14). This type
of interaction has been demonstrated for the Mix.2, goosecoid
and Xvent2 promoters where Smads interact with FAST-1,
FAST-2, mixer, milk and OAZ transcription factors (12). DNA
binding by Smad3, in conjunction with TFE3, PEBP2, and
ATF-2 to their cognate sites, has been reported to be essential
for TGF-b-dependent activation of the PAI-1, IgA, and colla-
genase A promoters respectively (12). Some of these coopera-
tivities may be involved in mediating signals for other signal-
ing pathways, as suggested by recent studies that described a
physical interaction of liganded VDR, Smad3, and SRC-1/TIF2
mediating cross-talk between vitamin D and TGF-b signaling
pathways (8, 9).
In the present study, we identified functional TGF-b-re-
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sponse elements in the human osteocalcin (hOC) gene pro-
moter; demonstrated cross-talk between vitamin D and TGF-b
signaling pathways in regulation of this promoter; and deter-
mined the molecular mechanism for synergistic activation of
the hOC promoter by vitamin D and TGF-b.
EXPERIMENTAL PROCEDURES
Plasmid Constructs—Reporter plasmids pOSLUC2 (21.3 kb) and
pOSLUC1 (2344 bp), of the human osteocalcin gene promoter linked
upstream of the luciferase reporter of pGL-3basic have been described
previously (15). pOSLUC3 (21.3 kb to 21111 plus 2905 to 2833) was
created by deletion of a StuI fragment from pOSLUC2. Deletion of the
PstI and SacI fragment from pOSLUC2 resulted in pOSLUC4 (21.3 kb
to 2833 plus 2341). pOSLUC5 (21.3 kb to 2341 plus 2191) was
constructed by deletion of the SacI and ApaI fragment from pOSLUC2.
pOSLUC6 was created by cloning in an osteocalcin promoter PCR
fragment (forward primer 21337 to 21311 with MluI 59 overhang and
reverse primer 2475 to 2500 with XhoI 59 overhang) into the pGL-3
promoter vector. The p3TP-Lux reporter, which contains SBEs from the
plasminogen activator inhibitor-1 (PAI-1) gene in front of the luciferase
reporter, was a kind gift from Dr. J. Massague (16). Double-stranded
oligonucleotides corresponding to human osteocalcin VDRE (2507 to
2470 or 2515 to 2484) or rat osteocalcin VDRE (2515 to 2484) were
cloned upstream of the SV40 promoter of pGL-3 promoter vector to
produce hVDREluc and rVDREluc respectively. hVDRE-3TPlux was
created by inserting the hVDREs in front of the SBEs from the p3TP-
Lux plasmid. Insertion of 450 bp fragment, which do not contain known
SBEs from pSG5 expression vector, between VDRE and SBEs of
hVDRE-3TPlux into XhoI site resulted in the V450T reporter plasmid.
VDR expression vector, mVDR-pSG5 and FLAG-Smad2,3,4/pcDNA3
plasmids that express Smad2, 3, or 4 with N-terminal FLAG tags have
been described elsewhere (15, 17). FLAG-S3-(41–435) that expresses
Smad3 with an N-terminal 41 amino acid deletion was a kind gift from
Dr S. Kato (8).
Cell Culture and Transfections—COS-1 cells were grown in Dulbec-
co’s modified Eagle medium supplemented with 5% fetal calf serum, 2
mM L-glutamine, 100 IU/ml penicillin and 100 mg/ml streptomycin (all
from Life Technologies, Inc.) at 37 °C in 5% CO2. Cells were plated at
;30% confluence in 24-well plates and the following day were trans-
fected using FuGENE-6 transfection reagent (Roche Molecular Bio-
chemicals, Indianapolis, IN) with 250 ng/well of reporter plasmid and
50 ng of the VDR or Smad expression plasmid. After a 6-h incubation at
37 °C in 5% CO2, 2% charcoal stripped fetal calf serum containing
medium was added having either 10 nM 1,25-dihydroxy vitamin D3
(Hoffman-LaRoche) or vehicle (isopropyl alcohol, final conc. 0.01%)
and/or TGF-b (1 ng/ml) (Sigma, Saint Louis, MI) or vehicle (4 nM HCl in
1 mg/ml bovine serum albumin). Following incubation for 16 h, cells
were lysed with 23 Promega lysis buffer, and luciferase assays were
performed in triplicate with the firefly luciferase assay kit (Promega,
Madison, WI) and measured using a Berthold LB953 Autolumat lumi-
nometer (Berthold, Bad Wildbad, Germany). Each experimental condi-
tion was measured in triplicates, and the values given represent the
mean 6 S.D. from two to three experiments.
Gel Shift Assays—Oligonucleotides were endlabeled by T4 polynu-
cleotide kinase using [g-32P]ATP (3,000 Ci/mmol, Amersham Pharma-
cia Biotech). DNA binding reactions of 20 ml were carried out in buffer
containing 20 mM Tris-Cl, pH 8.0, 10% (W/V) glycerol, 1 mM EDTA, 1
mM dithiothreitol, 400 ng of poly(dI-dC) (Amersham Pharmacia Bio-
tech), 75 mM KCl, 3% bovine serum albumin, 0.1–0.3 ng of radiolabeled
oligonucleotide, and 2 ml of Smad3 and Smad4 proteins transcribed and
translated in vitro, in rabbit reticulocyte lysate (Promega, Madison,
WI). Binding reactions were performed in room temperature for 20 min.
Free and bound DNA were separated on 4% polyacrylamide (acrylam-
ide/bisacrylamide, 29:0.5) gels, which were run at a constant voltage of
250 V in 22 mM Tris-borate, 0.5 mM EDTA (6).
RESULTS
Vitamin D and TGF-b Synergistically Activated Human
Osteocalcin Promoter Activity—The modulatory effects of 1,25-
dihydroxyvitamin D3 and TGF-b signaling on the human os-
teocalcin promoter were analyzed by transient transfections
into COS1 cells using the pOSLUC2 reporter and VDR expres-
sion plasmid. 1,25-Dihydroxyvitamin D3 transactivated the
pOSLUC2 reporter activity by 6-fold whereas TGF-b alone
augmented the reporter activity 2-fold (Fig. 1). Both ligands,
produced a synergistic effect (10-fold induction). This synergy
was specific to the pOSLUC2 reporter, because these two li-
gands together or singly did not significantly alter transcrip-
tional activity of pOSLUC1, which lacks 960 bp of distal 59
DNA sequence from the human osteocalcin promoter including
the VDRE (15). Smad3 and Smad2, but not BMP Smads
(Smad1 or Smad5), activated the osteocalcin promoter reporter
(data not shown), both in the absence and presence of TGF-b.
Augmentation of reporter activity was greater with Smad3,
suggesting a putative Smad3 binding site conferred the TGF-b
signal for this promoter. Overexpression of Smads 3 and 4
constitutively activated basal promoter activity mimicking
TGF-b signaling, as has been reported for other well charac-
terized TGF-b responsive promoters (11, 12).
TGF-b Did Not Augment 1,25-Dihydroxyvitamin D3 Activa-
tion of VDRE-dependent Reporters—To investigate whether the
synergistic activity observed in our previous experiment was in
fact mediated through the VDRE (4), the hVDREluc reporter
was co-transfected with a VDR expression plasmid into COS1
cells. Whereas 1,25-dihydroxyvitamin D3 increased the re-
porter activity 10-fold, TGF-b did not affect reporter activity
(Fig. 2A), nor was there any synergy between 1,25-dihydroxyvi-
tamin D3 and TGF-b, as observed in the case of the pOSLUC2
reporter. As the DR3 VDRE in the human osteocalcin promoter
overlaps a DR6 VDRE and an AP1 site, testing of these over-
lapping elements (2515 to 2484) was carried out in a luciferase
reporter construct. This construct also responded to 1,25-dihy-
droxyvitamin D3 but did not respond to TGF-b, and there was
no synergy between 1,25-dihydroxyvitamin D3 and TGF-b (Fig.
2B). Comparable experiments performed with the rVDREluc
reporter had a similar 1,25-dihydroxyvitamin D3 but no re-
sponse to TGF-b and no synergy between 1,25-dihydroxyvita-
min D3 and TGF-b signals, irrespective of nucleotide differ-
ences in human and rat VDREs (Fig. 2C). These results suggest
that VDRE alone is not sufficient to mediate the synergy.
1,25-Dihydroxyvitamin D3 Did Not Augment TGF-b Induc-
tion of a TRE-dependent Reporter—Possible effects of 1,25-
FIG. 1. 1,25-dihydroxyvitamin D3 (VD3) and TGF-b-activated
OC promoter. The human osteocalcin promoter conferred both 1,25-
dihydroxyvitamin D3 and TGF-b signaling to a luciferase reporter. The
pOSLUC2 or pOSLUC1 reporter was transiently co-transfected with
VDR expression plasmid into COS1 cells, and 1,25-dihydroxyvitamin
D3 (VD3) and/or TGF-b-induced luciferase activity was measured and
related to the uninduced reporter activity.
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dihydroxyvitamin D3 on TGF-b transcriptional activation were
tested on a heterologous reporter construct carrying the well
characterized TRE from the PAI-1 gene (p3TP-Lux) in COS1
cells (16). Whereas TGF-b activated the reporter in these cells
7-fold, 1,25-dihydroxyvitamin D3 had no effect on the basal
activity of the reporter (Fig. 3A). Moreover, TGF-b-activated
transcription was not augmented by 1,25-dihydroxyvitamin D3
(Fig. 3A). This result suggests that the TRE alone is incapable
of converging vitamin D and TGF-b signaling pathways.
VDRE Coupled to the TRE Sequence Restored Synergy by
Vitamin D and TGF-b Signaling Pathways—To explore
whether the synergy by 1,25-dihydroxyvitamin D3 and TGF-b
pathways required concomitant binding of both VDR and Smad
to their separate cognate elements, the hVDRE-3TPlux re-
porter plasmid, which contains both respective response ele-
ments, was co-transfected with VDR expression plasmid in
COS1 cells. 1,25-Dihydroxyvitamin D3 or TGF-b alone acti-
vated this reporter approximately by 10-fold (Fig. 3B). Impor-
tantly, hVDRE-3TPlux reporter responded synergistically to
1,25-dihydroxyvitamin D3 and TGF-b (45-fold), suggesting
both binding sites are needed to mediate the synergy (Fig. 3B).
Smad3-Smad4 Heterodimer Binding to Osteocalcin Promot-
er—Sequence analysis of the human osteocalcin promoter iden-
tified three regions: 2415 to 2353 (SBE1); 2313 to 2228
(SBE2); and 21027 to 2997 (SBE3); each of which contains
three copies of GTCT or its reverse complement AGAC, an
optimal target/binding site for Smad3 and Smad4 (13). Gel
shift assays using Smad3 and Smad4 proteins, transcribed and
translated in vitro in rabbit reticulocyte lysate, were used to
examine DNA binding activity of these putative SBEs as well
as the PE2 fragment of the PAI-1 promoter (13) as a positive
Smad binding control. SBE1 and SBE3 formed complexes sim-
ilar to PE2 (Fig. 4) whereas there was no complex formation
with SBE2 (data not shown). Rabbit reticulocyte lysate alone
did not form any complexes with these DNA probes (data not
shown). DNA binding specificity of complexes formed with
DNA probes, was examined using cold DNA probes as compet-
itors. Both SBE1 and SBE3 inhibited complex formation. How-
ever the PE2 element (2586 to 2551) from the PAI-1 promoter,
which contained three AGAC motifs, moderately inhibited the
complex formation with either SBE1 or SBE3.
Smad3-Smad4-mediated TGF-b-responsive Regions in the
Osteocalcin Promoter—To determine functional significance of
the Smad binding to the potential SBEs in the promoter, we
made deletions of larger regions from the pOSLUC2 (21.3 kb)
that removed SBE2, SBE1, and/or SBE3 (pOSLUC3–6).
Cotransfection of Smad3 and Smad4 expression vectors with
reporter plasmids pOSLUC1-6 augmented basal and TGF-b-
dependent activity (Fig. 5). The highest activation was
observed with the wild-type promoter reporter, pOSLUC2. De-
letion of SBE1 (pOSLUC4) greatly affected Smad3-mediated
augmentation whereas a moderate reduction was observed
with the deletion of SBE3 (pOSLUC3), both of which reflected
the previous binding studies that SBE1 and SBE3 were capable
of binding to Smad3 and Smad4. Deletion of SBE2 (pOSLUC5),
which did not bind with Smad3 and Smad4 in the gel shift
assay (data not shown), did not affect the reporter activity.
Combined deletion of SBE1 and SBE3 (pOSLUC1) or SBE1 and
SBE2 (pOSLUC6) also resulted in marked loss of reporter
activity. These results suggest that the Smad-mediated activity
was largely through the SBE1.
VDRE and TRE Spacing Crucial for 1,25-Dihydroxyvitamin
D3 and TGF-b Synergy—The role of the spacing between VDRE
and TRE in the 1,25-dihydroxyvitamin D3 and TGF-b synergy
was examined using V450T reporter plasmid. This construct,
containing both VDRE and TRE separated by 450 bp, was
co-transfected with VDR expression plasmid in COS1 cells.
This reporter activation by 1,25-dihydroxyvitamin D3 or TGF-b
FIG. 2. VDRE-linked heterologous promoters were not suffi-
cient to convey TGF-b signaling to a luciferase reporter. hVDRE-
luc (DR3, A), hVDREluc (DR316, B), and rVDREluc (C) reporters were
transiently co-transfected with VDR expression plasmid into COS1
cells, and 1,25-dihydroxyvitamin D3 (VD3) and/or TGF-b-induced lucif-
erase activity was measured and related to each uninduced reporter
activity.
FIG. 3. Presence of a TRE sequence was essential to convey
TGF-b signaling through VDRE-linked heterologous promoters.
p3TP-Lux (A) and hVDRE-3Tplux (B) reporters were transiently co-
transfected with VDR expression vector into COS1 cells, and 1,25-
dihydroxyvitamin D3 (VD3) and/or TGF-b-induced luciferase activity
were measured in luciferase units. All luciferase activities were related
to uninduced reporter activity.
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alone or in combination was remarkably reduced (Fig. 6) in
comparision to the parent hVDRE-3TPlux reporter plasmid
(Fig. 3B). The level of reduced synergy conferred by V450T was
comparable with pOSLUC6 reporter that has the VDRE and
SBE3 at a similar 450-bp distance. This result demonstrated
that synergy by 1,25-dihydroxyvitamin D3 and TGF-b signal-
ing, conferred via their respective transducers VDR and
Smad3, only occurred through binding to VDRE and TRE lo-
cated in the close proximity in the target promoter.
Direct Interaction between VDR and Smad3 Also Required
for Synergy—It was previously demonstrated that the
40-amino acid N-terminally truncated Smad3 did not physi-
cally interact with VDR in either GST pull-down assays or the
mammalian two-hybrid system, whereas the 20-amino acid
N-terminally truncated Smad3 retained such abilities (8). We
examined whether these Smad3 mutants together with VDR
were capable of synergistically activating the hVDRE-3TPlux
reporter. The wild-type Smad3 and Smad3-(21–435), capable of
transducing TGF-b signal, together with VDR synergistically
transactivated this reporter (Fig. 7). Smad3-(41–345) failed to
mediate TGF-b signaling, and with VDR, was unable to trans-
activate synergistically as Smad3, suggesting that a competent
Smad3 in addition to separate and distinct binding sites is also
required for the synergy.
DISCUSSION
DNA-binding nuclear factors interact with one another and
with cofactors to form complex networks of DNA-protein-pro-
tein interactions for transcriptional regulation in eukaryotic
cells (5, 8). Transcription regulatory regions of eukaryotic gene
promoters generally consist of clusters of transcription factor-
binding sites that coordinate responses to combinations of sig-
naling molecules and different transcription factors utilize a
variety of means to promote or repress target genes. (19).
Osteocalcin gene expression is facilitated by overlapping and
contiguous regulatory elements including a functional VDRE
in the distal promoter region (4, 20, 21). Regulatory factors,
including VDR, Cbfa-1, AP-1 factors, and homeodomain
proteins act directly, and BMPs and TGF-b act indirectly to
mediate commitment to the osteoblastic cell lineage and regu-
lation of the osteocalcin promoter (22, 23).
Only two reports to date describe transcriptional regulation
through protein-protein interaction involving Smad3 and nu-
clear hormone receptors (8, 24). Whereas Yanagisawa et al. (8)
reported that activation by VDR, but not other receptors (oes-
trogen receptor a, androgen receptor, GR, retinoic acid recep-
tor, and RXR), was affected by the treatment with TGF-b, Song
et al. (24) found that Smad3 was the direct target for repression
by the GR on a type-1 PAI-1 gene promoter. They provided
evidence for GR-Smad3 interaction in vivo and in vitro, al-
though they could not rule out the possibility that other pro-
teins might have mediated the interaction.
A structure/function analysis of the hOC promoter was ini-
tiated to explore its synergistic activation by vitamin D and
TGF-b (Fig. 1). Recently it has been reported that Smad3, a
downstream component of the TGF-b signaling pathway, acts
FIG. 4. Smad3 and Smad4 binding to SBE1 and SBE3 in vitro.
In vitro-produced Smad3 and Smad4 proteins (2 ml) were incubated
with radiolabeled SBE1, SBE2, SBE3, and PE2 and analyzed by gel
shift assay. A 50-fold excess of unlabeled SBE1, SBE3, or PE2, a
fragment of the PAI-1 promoter (13), were included in the incubation
reaction before the assay.
FIG. 5. Smad3 and Smad4 activated the osteocalcin promoter
mainly through SBE1. pOSLUC1, pOSLUC2, pOSLUC3, pOSLUC4,
pOSLUC5, and pOSLUC6 reporters were co-transfected with empty
vector or Smad3 and Smad4 expression plasmids into COS-1 cells, and
cells were treated with or without TGF-b. All luciferase activities were
related to individual uninduced reporter activity.
FIG. 6. Spacing between VDRE and TRE affects synergy. The
V620T, V450T, or pOSLUC6 reporters were transiently co-transfected
with VDR expression plasmid into COS1 cells, and 1,25-dihydroxyvita-
min D3 (VD3) and/or TGF-b-induced luciferase activity were measured
and related to individual uninduced reporter activity.
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as a coactivator of VDR potentiating its ligand-induced trans-
activation (8, 9). Hence, we tested the VDRE from the hOC
promoter as a separate response element in the context of a
minimal heterologous promoter. There was no synergy between
1,25-dihydroxyvitamin D3 and TGF-b signals through this
VDRE (Fig. 2A). In addition, the slightly longer VDRE, which
contained both DR6 and DR3 spacing, exhibited no synergy in
transient transfection studies in COS-1 cells by these signals
(Fig. 2B). A rat osteocalcin DR3-type of VDRE placed in heterol-
ogous context also did not mediate synergistic effects of 1,25-
dihydroxyvitamin D3 and TGF-b (Fig. 2C). These results sug-
gested that nucleotide differences in different minimal VDREs
cannot explain the failure to observe TGF-b-mediated reporter
activity. In addition, similar results were obtained in three sep-
arate cell lineages, suggesting differences in cellular context
could not be responsible for the disparity of the results. These
data are not consistent with direct protein-protein interaction as
the sole mode of action to explain the synergy, and therefore are
in sharp contrast to the findings of Yanagisawa et al.(8, 9) who
reported that the VDRE alone was sufficient for convergence of
1,25-dihydroxyvitamin D3 and TGF-b signaling pathways.
Disparity between our results and previously reported re-
sults may be attributed to the design of the reporter construct
used in the transient transfection studies. Constructs in Ref. 8
derived from pGCAT (25) and contained a synthetic oligonu-
cleotide insert with HindIII and XbaI sites. This XbaI site
follows GT nucleotide of the parental plasmid sequence and
creates a DNA sequence 59-GTCT-39, which has been defined as
a Smad box (12) and could form part of a cryptic SBE in close
proximity to the VDRE. Potentially, the presence of these two
closely spaced sites could be mediating the synergy between
1,25-dihydroxyvitamin D3 and TGF-b signals in their reporter
construct. Irrespective of these reasons, in our studies, conver-
gence of vitamin D and TGF-b signaling required both specific
DNA response elements in both heterologous promoter model
constructs and in the human osteocalcin promoter.
The ability of the Smad3-Smad4 complex alone or in the
presence of TGF-b to transactivate the OSLUC2 reporter is
consistent with the existence of Smad binding sites in this
promoter. This led us to test the activation of reporters con-
taining both a VDRE (human) and a cluster of TGF-b response
elements from the PAI-1 gene, upstream of the SV40 promoter.
Transient transfection studies with these reporter constructs
recreated the synergy between vitamin D and TGF-b signals,
with activation by vitamin D comparable with the induction of
hVDREluc reporter (Fig. 2A), and TGF-b stimulated activation
comparable with that of the standard TGF-b responsive re-
porter p3TP-Lux (Fig. 3A). Of three potential SBE clusters in
the osteocalcin promoter, two (SBE1 and SBE3) bound to
Smad3 and Smad4 proteins in a gel shift assay (Fig. 4). Dele-
tion of these two putative regions separately or together
reduced TGF-b-mediated reporter activity confirming their
functional role (Fig. 5). Taken together, these results suggest
that the convergence of TGF-b and vitamin D signaling does
not take place in the absence of either VDRE or TRE. In
agreement with these data, a Smad3-Smad4 complex and an
AP-1 complex have been reported to synergize in transcrip-
tional activation of the c-jun promoter by binding to separate
sites 120 bp apart (26). Similarly, transcriptional cooperativity
between c-Jun and Smad3 at the AP-1 binding site of the
collagenase I promoter also required the interaction of c-Jun
and Smad3 with DNA (27). Several other recent reports point
to cross-talk between Smad proteins and transcription factors
such as TFE3, FAST-1, SP1, CREB, and Tinman in the expres-
sion of various TGF-b-inducible genes (Ref. 13 and references
therein). It has been proposed that the number of SBEs as well
as discrete spacer segments between SBEs and/or Smad-part-
ner transcription factor binding site(s) will also be critical for
the specificity of TGF-b-induced transcription of these prom-
oters (13). Our study also found that the synergy by vitamin D
and TGF-b was reduced when the spacing between VDRE and
TRE was extended (Fig. 6).
The promoter studies further indicate that simultaneous
binding of VDR and Smad3 to their cognate sequences (Fig. 3B)
and possibly a direct interaction between these two proteins
(Fig. 7), are both required for the convergence of the vitamin D
and TGF-b signals. The Smad3-(41–345) construct failed to
mediate TGF-b signaling through the 3TPlux reporter (data
not shown) suggesting that this Smad3 mutant is functionally
inert. The same N-terminal deletion mutant failed to interact
with VDR (8). Our study also found that this mutant was
unable to transactivate synergistically with VDR through
hVDRE-3TPlux reporter, therefore we could not positively con-
clude that a direct VDR-Smad3 interaction was involved in the
cross-talk between these regulatory pathways.
In the present study we demonstrated that the VDRE-con-
taining hOC gene promoter contains two functional Smad3
binding elements through which the TGF-b and vitamin D
signaling pathways converge. Our data thus strongly suggest
that cross-talk between these two signaling pathways requires
the presence in the promoter of both respective response ele-
ments in close proximity. These data support the concept of
specific response elements being required to transduce both
single agents and to integrate the synergistic activation of
hormone responsive genes.
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FIG. 7. Competent Smad3 required for synergy in vivo. hVDRE-
3TPlux reporter was transiently co-transfected with VDR and in the
absence or presence of Smad3 or S3-(21–435), S3-(41–435) expression
vector into COS-1 cells, and 1, 25-dihydroxyvitamin D3 (VD3) and/or
TGF-b-induced luciferase activity was measured and related to unin-
duced reporter activity.
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